Hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) account for roughly 70% and 15% of all primary liver cancers, respectively. Additionally, metastatic disease to the liver (MDL) ...

Gan Partners, together with its funds ( is pleased to announce its investment in Adenocyte™ ( a medical technology company ...

Primary central nervous system (CNS) malignancies present unique therapeutic challenges due to their complex biology, immunosuppressive microenvironment, ...

Dubbed “the next frontier of cancer prevention and care,” the microbiome appears to be especially critical when it comes to ...

A drug widely used to combat intestinal worms has shown promise in treating brain tumors, with scientists calling for more ...

Imagine a future where cancer treatment affects only the tumor, where eye injections are no longer required and brain ...

A team of experimental oncology researchers at the University of Alberta is shedding light on how the deadly brain cancer ...

Amberwell Health and Mosaic Life Care announced Monday that they will partner to launch Amberwell Cancer Care, a new program bringing chemothearpy, infusion therapy and onsite ...

The landmark success of a drug against an ‘undruggable’ cancer is spurring fresh optimism in the quest to treat seemingly untouchable tumour targets. The experimental drug, daraxonrasib, disarms all ...

The hospital now offers Pluvicto to battle advanced prostate cancer, the Thor device to prevent mouth sores during chemotherapy and a new kind of cooling cap therapy to help patients keep their hair ...

When news breaks, you need to understand what actually matters — and what to do about it. At Vox, our mission to help you make sense of the world has never been more vital. But we can’t do it on our ...

A common over-the-counter medication combined with a home exercise program could help ease cognitive issues for cancer patients. That’s according to a study from the University of Rochester, which ...